HealthEquity Beats Q2, Raises FY27 Guidance to $2.88-$2.96 EPS
HQY sits 40% above its 52-week low of $72.76.
Summary
HealthEquity reported record Q2 FY27 results with 8% revenue growth and raised full-year guidance, while repurchasing $108.1M in stock.
Key Events · Earnings and Guidance · HQY
-
Record Q2 Results
Revenue rose 8% to $350.7M; net income increased 10% to $65.6M ($0.78 diluted EPS); Adjusted EBITDA grew 11% to $167.0M with a record 48% margin.
-
Raised FY27 Guidance
Management now expects revenue of $1.411B-$1.421B, GAAP EPS of $2.88-$2.96, and non-GAAP EPS of $4.66-$4.73 — up from prior outlook.
-
Share Repurchase Update
Repurchased 1.2M shares for $108.1M in Q2; $948.4M remains authorized under the expanded buyback program.
-
HSA Asset Growth
Total HSA Assets grew 14% YoY to $37.9B; HSA accounts reached 10.7M, up 8% YoY.
Analysis · HQY · Trade & Services
Record Q2 results underscore HealthEquity's momentum, with revenue climbing 8% to $350.7M and Adjusted EBITDA margin expanding to 48%. Full-year guidance was raised across all key metrics, and the company returned $108.1M to shareholders through buybacks, continuing its aggressive capital return program. The raised FY27 EPS guidance of $2.88-$2.96 likely exceeds analyst expectations, as noted in today's Dow Jones report, making this a positive catalyst for the stock.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HQY was trading at $102.00 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $72.76 to $107.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.